EVH - Evolent Health, Inc.
NYSE
->
Healthcare
->
Health Information Services
Arlington,
United States
Type: Equity
EVH price evolution
EVH
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $101.25 | $165.15 | $192.82 | |
| Short term investments | $20.05 | $51.59 | $13.77 | |
| Net receivables | $407.9 | $373.73 | $427.74 | $446.75 |
| Inventory | ||||
| Total current assets | $544.01 | $520.97 | $669.25 | $683.67 |
| Long term investments | $25.02 | $24.93 | $21.76 | |
| Property, plant & equipment | $83.19 | $85.2 | $86.83 | $90.18 |
| Goodwill & intangible assets | $1827.83 | $1847.88 | $1868.55 | |
| Total noncurrent assets | $1954.14 | $1974.43 | $1996.63 | |
| Total investments | $45.07 | $76.53 | $35.53 | |
| Total assets | $2501.76 | $2475.11 | $2643.67 | $2680.31 |
| Current liabilities | ||||
| Accounts payable | $50.09 | $39.03 | $77.35 | $48.25 |
| Deferred revenue | $4.56 | $6.14 | $5.98 | |
| Short long term debt | $6.13 | $12.7 | $9.74 | |
| Total current liabilities | $523.68 | $483.37 | $659.02 | $674.24 |
| Long term debt | $599.67 | $629.57 | $630.37 | $635.06 |
| Total noncurrent liabilities | $753.67 | $755.42 | $759.94 | |
| Total debt | $635.71 | $643.07 | $644.8 | |
| Total liabilities | $1275.91 | $1237.04 | $1414.44 | $1434.18 |
| Shareholders' equity | ||||
| Retained earnings | -$758.01 | -$734.88 | -$736.47 | -$719.19 |
| Other shareholder equity | -$1.37 | -$1.35 | -$1.31 | -$1.26 |
| Total shareholder equity | $1053.86 | $1229.23 | $1067.7 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $192.82 | $188.2 | $266.28 | $340.49 |
| Short term investments | $13.77 | $14.49 | $75.69 | $18.3 |
| Net receivables | $446.75 | $254.68 | $130.6 | $125.99 |
| Inventory | ||||
| Total current assets | $683.67 | $478.05 | $523.96 | $546.13 |
| Long term investments | $21.76 | $16.94 | $18.43 | $24.69 |
| Property, plant & equipment | $90.18 | $136.9 | $131.57 | $144.04 |
| Goodwill & intangible assets | $1868.55 | $1165.56 | $706.08 | $622.81 |
| Total noncurrent assets | $1996.63 | $1339.24 | $895.5 | $824.05 |
| Total investments | $35.53 | $31.43 | $94.12 | $42.98 |
| Total assets | $2680.31 | $1817.29 | $1419.46 | $1370.18 |
| Current liabilities | ||||
| Accounts payable | $48.25 | $57.17 | $96.08 | $32.07 |
| Deferred revenue | $5.98 | $5.76 | $11.94 | $14.33 |
| Short long term debt | $9.74 | $7.12 | $7.07 | $33.91 |
| Total current liabilities | $674.24 | $433.44 | $445.49 | $401.78 |
| Long term debt | $635.06 | $412.99 | $273.4 | $325.87 |
| Total noncurrent liabilities | $759.94 | $524.43 | $280.33 | $348.81 |
| Total debt | $644.8 | $476.12 | $280.47 | $359.78 |
| Total liabilities | $1434.18 | $957.88 | $725.83 | $750.59 |
| Shareholders' equity | ||||
| Retained earnings | -$719.19 | -$606.15 | -$626.78 | -$589.18 |
| Other shareholder equity | -$1.26 | -$1.18 | -$0.36 | -$0.28 |
| Total shareholder equity | $1067.7 | $859.42 | $693.63 | $619.6 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $621.4 | $639.65 | $556.05 | |
| Cost of revenue | $535.55 | $454.43 | ||
| Gross Profit | $80.69 | $104.11 | $101.63 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $79.1 | $81.43 | ||
| Total operating expenses | $93.16 | $108.61 | $117.04 | |
| Operating income | -$4.5 | -$15.41 | ||
| Income from continuing operations | ||||
| EBIT | -$10.72 | -$14.59 | ||
| Income tax expense | -$0.62 | $0.56 | -$14.66 | |
| Interest expense | -$7.45 | $6 | $12.24 | |
| Net income | ||||
| Net income | -$31.23 | -$17.28 | -$12.18 | |
| Income (for common shares) | -$25.23 | -$41.4 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1963.9 | $1352.01 | $907.96 | $1022.43 |
| Cost of revenue | $1503.43 | $1035.43 | $657.55 | $789.32 |
| Gross Profit | $460.47 | $316.58 | $250.41 | $233.11 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $358.11 | $269.27 | $219.5 | $222.6 |
| Total operating expenses | $513.7 | $336.46 | $292.82 | $503.73 |
| Operating income | -$53.23 | -$19.88 | -$42.41 | -$270.62 |
| Income from continuing operations | ||||
| EBIT | -$148.2 | -$46.97 | -$11.69 | -$309.46 |
| Income tax expense | -$89.36 | -$43.38 | $0.48 | -$3.55 |
| Interest expense | $54.2 | $15.57 | $25.43 | $28.34 |
| Net income | ||||
| Net income | -$113.04 | -$19.16 | -$37.6 | -$334.25 |
| Income (for common shares) | -$142.26 | -$19.16 | -$37.6 | -$334.25 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$6.38 | -$17.28 | -$12.18 | |
| Operating activities | ||||
| Depreciation | $29.87 | $29.5 | $29.6 | |
| Business acquisitions & disposals | -$4.56 | -$1.39 | ||
| Stock-based compensation | $12.66 | $18.79 | $10.6 | |
| Total cash flows from operations | $21.42 | $4.91 | $89.38 | |
| Investing activities | ||||
| Capital expenditures | -$7.11 | -$5.35 | -$6.05 | |
| Investments | -$1.87 | -$3 | ||
| Total cash flows from investing | -$43 | -$13.54 | -$9.73 | -$6.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.06 | $1.06 | $3.34 | |
| Net borrowings | -$31.41 | $36.99 | -$34.71 | |
| Total cash flows from financing | -$97.51 | -$103.38 | $14.88 | -$84.35 |
| Effect of exchange rate | -$0.09 | -$0.02 | -$0.04 | -$0.02 |
| Change in cash and equivalents | -$95.61 | -$95.53 | $10.02 | -$1.04 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$113.04 | -$19.16 | -$37.6 | -$334.25 |
| Operating activities | ||||
| Depreciation | $123.42 | $67.19 | $60.04 | $61.48 |
| Business acquisitions & disposals | -$387.67 | -$226.31 | -$2.53 | $159.46 |
| Stock-based compensation | $40.5 | $33.98 | $16.71 | $14.61 |
| Total cash flows from operations | $142.58 | -$11.55 | $38.75 | -$16.23 |
| Investing activities | ||||
| Capital expenditures | -$28.75 | -$38.36 | -$24.98 | -$29.47 |
| Investments | $0.87 | $5.55 | $11.72 | $133.38 |
| Total cash flows from investing | -$415.54 | -$259.12 | -$15.79 | $261.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $12.52 | $4.45 | $13.29 | $2.58 |
| Net borrowings | $181.78 | $160.29 | -$37.69 | $7.41 |
| Total cash flows from financing | $281.34 | $131.54 | -$29.55 | -$11.86 |
| Effect of exchange rate | -$0.08 | -$0.66 | -$0.05 | $0.07 |
| Change in cash and equivalents | $8.3 | -$139.78 | -$6.64 | $233.05 |
News
Fundamentals
| Market cap | $1.15B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 115.01M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 21.60% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.34 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.04 |
| Quick ratio | N/A |